X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2076) 2076
Book Review (341) 341
Publication (235) 235
Conference Proceeding (5) 5
Book Chapter (4) 4
Dissertation (3) 3
Magazine Article (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1914) 1914
index medicus (1869) 1869
erlotinib hydrochloride (1404) 1404
oncology (1279) 1279
erlotinib (1233) 1233
female (1097) 1097
lung neoplasms - drug therapy (1021) 1021
male (991) 991
carcinoma, non-small-cell lung - drug therapy (923) 923
middle aged (855) 855
quinazolines - administration & dosage (846) 846
aged (822) 822
gefitinib (661) 661
receptor, epidermal growth factor - antagonists & inhibitors (632) 632
chemotherapy (631) 631
antineoplastic combined chemotherapy protocols - therapeutic use (630) 630
quinazolines - therapeutic use (589) 589
adult (581) 581
cancer (552) 552
lung neoplasms - pathology (514) 514
treatment outcome (504) 504
protein kinase inhibitors - therapeutic use (450) 450
mutation (444) 444
carcinoma, non-small-cell lung - pathology (435) 435
lung cancer, non-small cell (424) 424
receptor, epidermal growth factor - genetics (418) 418
quinazolines - adverse effects (416) 416
antineoplastic agents - therapeutic use (396) 396
care and treatment (387) 387
lung cancer (384) 384
aged, 80 and over (376) 376
cell lung-cancer (374) 374
growth-factor receptor (368) 368
epidermal growth factor (362) 362
lung neoplasms - genetics (344) 344
animals (327) 327
protein kinase inhibitors - administration & dosage (319) 319
egfr (317) 317
carcinoma, non-small-cell lung - genetics (309) 309
disease-free survival (299) 299
erlotinib hydrochloride - administration & dosage (296) 296
tyrosine kinase inhibitor (295) 295
therapy (289) 289
cell line, tumor (273) 273
neoplasm staging (271) 271
respiratory system (271) 271
hematology, oncology and palliative medicine (270) 270
pharmacology & pharmacy (253) 253
adenocarcinoma - drug therapy (249) 249
non-small cell lung cancer (249) 249
deoxycytidine - analogs & derivatives (245) 245
quinazolines - pharmacology (244) 244
antineoplastic agents - administration & dosage (240) 240
research (228) 228
analysis (226) 226
mice (225) 225
protein kinase inhibitors - adverse effects (225) 225
respiratory tract diseases (225) 225
receptor, epidermal growth factor - metabolism (224) 224
bevacizumab (223) 223
deoxycytidine - administration & dosage (219) 219
lung neoplasms - mortality (214) 214
antineoplastic combined chemotherapy protocols - adverse effects (212) 212
tyrosine (210) 210
gemcitabine (209) 209
trial (205) 205
open-label (204) 204
carcinoma, non-small-cell lung - mortality (203) 203
drug therapy (203) 203
epidermal growth factor receptor (202) 202
medicine & public health (202) 202
phase-iii trial (201) 201
prognosis (200) 200
survival (200) 200
tumors (197) 197
cetuximab (190) 190
antibodies, monoclonal, humanized (189) 189
combination (189) 189
tyrosine kinase inhibitors (187) 187
pancreatic neoplasms - drug therapy (185) 185
antineoplastic agents - adverse effects (183) 183
adenocarcinoma (175) 175
protein kinase inhibitors - pharmacology (174) 174
pulmonary/respiratory (172) 172
survival rate (172) 172
mutations (171) 171
expression (170) 170
1st-line treatment (168) 168
acquired-resistance (167) 167
antineoplastic agents - pharmacology (164) 164
clinical trials (164) 164
erlotinib hydrochloride - therapeutic use (161) 161
metastasis (161) 161
nsclc (160) 160
dose-response relationship, drug (154) 154
dosage and administration (150) 150
antibodies, monoclonal - administration & dosage (148) 148
disease progression (146) 146
pancreatic cancer (142) 142
retrospective studies (142) 142
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1996) 1996
French (22) 22
Japanese (18) 18
Chinese (17) 17
German (13) 13
Spanish (5) 5
Polish (3) 3
Czech (2) 2
Hungarian (2) 2
Danish (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4, pp. 412 - 420
Journal Article
JAMA, ISSN 0098-7484, 05/2016, Volume 315, Issue 17, pp. 1844 - 1853
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 12, pp. 1309 - 1314
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 05/2016, Volume 229, pp. 80 - 92
Pretreatment of lung cancer cells with epidermal growth factor receptor (EGFR) inhibitor erlotinib has been recently reported that could dramatically synergize... 
pH-sensitive | Charge conversion | MSN | Erlotinib | DOX | Synergistic therapy | CLATHRIN-MEDIATED ENDOCYTOSIS | CELLS | DRUG-DELIVERY | CHITOSAN | TUMOR | CHEMISTRY, MULTIDISCIPLINARY | CELLULAR UPTAKE | PACLITAXEL | NANOPARTICLES | ENHANCED PERMEABILITY | CANCER-TREATMENT | PHARMACOLOGY & PHARMACY | Doxorubicin - therapeutic use | Drug Carriers - therapeutic use | Nanoparticles - chemistry | Apoptosis - drug effects | Benzoates - chemistry | Humans | Erlotinib Hydrochloride - chemistry | Drug Carriers - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Doxorubicin - chemistry | Antineoplastic Agents - administration & dosage | Drug Carriers - chemistry | Protein Kinase Inhibitors - chemistry | Nanoparticles - therapeutic use | Antineoplastic Agents - pharmacokinetics | Drug Therapy, Combination | Doxorubicin - administration & dosage | Protein Kinase Inhibitors - pharmacokinetics | A549 Cells | Cell Survival - drug effects | Erlotinib Hydrochloride - pharmacokinetics | Mice, Inbred C57BL | Erlotinib Hydrochloride - administration & dosage | Phosphatidylcholines - chemistry | Antineoplastic Agents - chemistry | Rats, Sprague-Dawley | Doxorubicin - pharmacokinetics | Carcinoma, Lewis Lung - drug therapy | Drug Synergism | Protein Kinase Inhibitors - administration & dosage | Animals | Drug Liberation | Drug Carriers - pharmacokinetics | Erlotinib Hydrochloride - therapeutic use | Nanoparticles - administration & dosage | Hydrogen-Ion Concentration | Membrane lipids | Anthracyclines | Epidermal growth factor | Hydrogen-ion concentration | Lung cancer | Surface active agents | Drug discovery | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2015, Volume 21, Issue 14, pp. 3196 - 3203
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2016, Volume 22, Issue 5, pp. 1103 - 1110
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2017, Volume 35, Issue 29, pp. 3330 - 3337
Journal Article
JAMA, ISSN 0098-7484, 03/2016, Volume 315, Issue 12, pp. 1266 - 1275
Journal Article
Biomaterials, ISSN 0142-9612, 11/2017, Volume 145, pp. 56 - 71
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 01/2017, Volume 246, pp. 120 - 132
In this study, we demonstrate for the first time the concurrent transdermal delivery of erlotinib and IL36α siRNA as a potential dual therapy for psoriasis.... 
Gene delivery | siRNA | Transdermal | Psoriasis | Skin delivery | Lipid nanocarriers | CARRIERS | CHEMISTRY, MULTIDISCIPLINARY | GROWTH-FACTOR RECEPTOR | NANOPARTICLES | INHIBITION | THERAPY | IN-VIVO | PHARMACOLOGY & PHARMACY | TRANSDERMAL DRUG-DELIVERY | LIPOSOMES | PERCUTANEOUS DELIVERY | TOPICAL DELIVERY | Interleukin-1 - genetics | Skin - metabolism | Humans | Male | Administration, Cutaneous | Drug Delivery Systems | Psoriasis - genetics | Psoriasis - pathology | HEK293 Cells | Skin - pathology | Psoriasis - therapy | Protein Kinase Inhibitors - pharmacokinetics | Gene Transfer Techniques | Psoriasis - drug therapy | Erlotinib Hydrochloride - pharmacokinetics | RNA, Small Interfering - pharmacokinetics | Mice, Inbred C57BL | Erlotinib Hydrochloride - administration & dosage | RNAi Therapeutics - methods | Protein Kinase Inhibitors - administration & dosage | Animals | Protein Kinase Inhibitors - therapeutic use | RNA, Small Interfering - therapeutic use | Erlotinib Hydrochloride - therapeutic use | RNA, Small Interfering - administration & dosage | Skin - drug effects | Atomic force microscopy | Erlotinib | Fluorescein | Skin care products | Skin | Drug therapy | Transdermal medication | Dermatology | Drugstores | Dermatologic agents | Tacrolimus | Pharmacy | Formulae, receipts, prescriptions | Mice | Index Medicus
Journal Article